Christi Shaw

Chief Executive Officer, Kite


Chris Shaw headshot

Ms. Shaw oversees all aspects of cell therapy at Gilead’s Kite business unit, with responsibility for all of the company’s 1,200 employees around the world.

Ms. Shaw joined from Eli Lilly & Company, where she served as senior vice president, Eli Lilly & Company and president, Lilly Bio-Medicines, leading the company’s broadest therapeutic portfolio and overseeing late-stage clinical development and commercialization. Her leadership has spanned a broad range of therapeutic areas, including oncology, cardiovascular, respiratory, dermatology, rheumatology, infectious disease, neuroscience, ophthalmology and medical devices.

Ms. Shaw currently serves on the boards of the Biotechnology Industry Organization; Avantor, a global manufacturer and distributor of products, services and solutions to professionals in the life sciences and advanced technology industries; and the Healthcare Women's Business Association. In 2017, she founded the More Moments More Memories Foundation to assist people with cancer and their caregivers.

Ms. Shaw earned a Master of Business Administration from the University of Wisconsin and a Bachelor of Business Administration from Iowa State University.